Suppr超能文献

维斯纳啉对人肝癌细胞系的抗肿瘤作用。

Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.

作者信息

Kubo K, Matsuzaki Y, Kato A, Terai S, Okita K

机构信息

First Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.

出版信息

Int J Oncol. 1999 Jan;14(1):41-6.

PMID:9863007
Abstract

Vesnarinone, a quinolinone derivative, induces apoptosis and differentiation in some tumor cell lines. We examined the antitumor effect of vesnarinone on three human hepatocellular carcinoma (HCC) cell lines. Vesnarinone suppressed the proliferation of all three HCC cell lines, but did not induce apoptosis and differentiation. Vesnarinone has also been reported to inhibit both nucleoside and nucleobase transport. Concomitant administration of vesnarinone and a de novo nucleotide synthesis inhibitor potentiated the growth-inhibitory effect of vesnarinone on HCC cells. Vesnarinone may be useful as a new biochemical modulator of anticancer agents.

摘要

维司那定,一种喹啉酮衍生物,可诱导某些肿瘤细胞系发生凋亡和分化。我们检测了维司那定对三种人肝癌(HCC)细胞系的抗肿瘤作用。维司那定抑制了所有三种HCC细胞系的增殖,但未诱导凋亡和分化。据报道,维司那定还可抑制核苷和核碱基转运。维司那定与一种从头合成核苷酸抑制剂联合给药可增强维司那定对HCC细胞的生长抑制作用。维司那定可能作为一种新型抗癌药物的生化调节剂发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验